Omada Health appoints Wei-Li Shao as new CEO as company ramps up GLP-1 strategy
Omada Health reported strong Q2 growth driven by demand for its integrated approach to managing chronic conditions such as diabetes, hypertension, obesity and musculoskeletal disorders.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.